R&D

  • World Drug Report 2026
    2026-07-06

    World Drug Report 2026

    The increasing availability of novel synthetic opioids comes at a time when there are severe constraints on the illicit production of heroin, together, these circumstances c...

    View More
  • 《2025年中国毒情形势报告》
    2026-07-03

    《2025年中国毒情形势报告》

    《2025年中国毒情形势报告》

    View More
  • European Drug Report 2026: Trends and Developments
    2026-07-03

    European Drug Report 2026: Trends and Developments

    欧洲毒品危机加剧:2024年7600人死亡、1050种新型毒品涌现,可卡因纯度飙升44%,半合成大麻素与致命硝氮烯正改写禁毒规则。当毒品披上"合法"外衣、假药混入流通渠道,这场化学战已超越国界。

    View More
  • Evaluation of Release of Donepezil Bilayer Microspheresin Vivo by LC-MSMS
    2026-06-17

    Evaluation of Release of Donepezil Bilayer Microspheresin Vivo by LC-MSMS

    Download:Evaluation of Release of Donepezil Bilayer Microspheresin Vivo by LC-MSMS.pdf

    View More
  • Research progress of naltrexone hydrochloride implants in patients with opioid use disorder
    2026-06-16

    Research progress of naltrexone hydrochloride implants in patients with opioid use disorder

    下载:Research progress of naltrexone hydrochloride implants in patients with opioid use disorder.pdf

    View More
  • Clinical efficacy and application evaluation of naltrexone implants
    2026-06-16

    Clinical efficacy and application evaluation of naltrexone implants

    Download:Clinical efficacy and application evaluation of naltrexone implants.pdf

    View More
  • Preparation and in Vitro and in Vivo Studies of Donepezil Implants
    2026-06-16

    Preparation and in Vitro and in Vivo Studies of Donepezil Implants

    Download:Preparation and in Vitro and in Vivo Studies of Donepezil Implants.pdf

    View More
  • Progresses in relationship between opioid receptor systemand depression and intervention strategies
    2026-06-15

    Progresses in relationship between opioid receptor systemand depression and intervention strategies

    下载:阿片受体作用系统与抑郁症发病及干预研究进展_吴宁.pdf

    View More
  • R Language Assisted Excipient Compatibility and Formulation Optimization of Epirubicin Tablets
    2026-06-15

    R Language Assisted Excipient Compatibility and Formulation Optimization of Epirubicin Tablets

    Download:R Language Assisted Excipient Compatibility and Formulation.pdf

    View More
  • Dry powder inhalers of conjugated linoleic acid for the treatment of primary lung cancer
    2026-06-12

    Dry powder inhalers of conjugated linoleic acid for the treatment of primary lung cancer

    DownloadDry powder inhalers of conjugated linoleic acid for the treatment of primary lung cancer.pdf

    View More
  • Global status report on alcohol and health and treatment of substance use disorders
    2026-06-11

    Global status report on alcohol and health and treatment of substance use disorders

    The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related harm and policy...

    View More
  • Long-Acting Risperidone Dual Control System: Preparation, Characterization and Evaluation In Vitro and In Vivo
    2026-06-10

    Long-Acting Risperidone Dual Control System: Preparation, Characterization and Evaluation In Vitro and In Vivo

    Abstract: Schizophrenia, a psychiatric disorder, requires long-term treatment; however, large fluctua tions in blood drug concentration increase the risk of adverse reacti...

    View More
  • A Membrane-­Centric Plasma Lipidomic Signature  of Response to Long-­Acting Naltrexone in Alcohol  Use Disorder
    2026-06-08

    A Membrane-­Centric Plasma Lipidomic Signature of Response to Long-­Acting Naltrexone in Alcohol Use Disorder

    ABSTRACTLong-­acting naltrexone is a first-­line pharmacotherapy for alcohol use disorder (AUD), but clinical response is heterogeneous and the underlying biology remains incomp...

    View More
  • Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients
    2026-06-08

    Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients

    Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients

    View More
  • Naltrexone Implants Clinical Application Guidelines
    2025-12-25

    Naltrexone Implants Clinical Application Guidelines

    Naltrexone Implants Clinical Application Guidelines

    View More
  • World Drug Report 2025
    2025-12-25

    World Drug Report 2025

    World Drug Report 2025

    View More